14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Diabetic Cardiomyopathies in 2 studies
14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation
Diabetic Cardiomyopathies: Diabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Diabetic cardiac hypertrophy was developed by high-fat diet feeding combined with streptozotocin (40 mg/kg/d for 5 days, i." | 1.72 | 14,15-EET involved in the development of diabetic cardiac hypertrophy mediated by PPARs. ( Ding, S; Jiang, C; Jiang, Q; Qiu, H; Wu, K; Yang, C; Yang, J; Zhang, J, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, J | 1 |
| Yang, C | 1 |
| Qiu, H | 1 |
| Yang, J | 1 |
| Wu, K | 1 |
| Ding, S | 1 |
| Jiang, C | 1 |
| Jiang, Q | 1 |
| Romashko, M | 1 |
| Schragenheim, J | 1 |
| Abraham, NG | 1 |
| McClung, JA | 1 |
1 review available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Epoxyeicosatrienoic Acid as Therapy for Diabetic and Ischemic Cardiomyopathy.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Cardiovascular Diseases; Diabetic Cardiomyopathies; Drug Desig | 2016 |
1 other study available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
14,15-EET involved in the development of diabetic cardiac hypertrophy mediated by PPARs.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Cardiomegaly; Diabetes Mellitus; Diabetic Cardiomyopathies; Gl | 2022 |